Partner Article
Yorkshire healthcare developers to benefit from partnership
Health industry experts Medipex have joined with Sheffield University’s National Metals Technology Centre (NAMTEC) to help Yorkshire SMEs developing healthcare products.
NAMTEC’s run the ERDF-funded Advanced Manufacturing Support programme which provides SMEs access to services to accelerate their route to market.
Medipex bring a comprehensive knowledge and experience of the NHS landscape, intellectual property, market intelligence and product development.
The organisation can offer these services to Yorkshire engineering and manufacturing businesses developing products aimed at the healthcare sector.
Chris Herbert, business development manager at Medipex, said: “Since the demise of Yorkshire Forward, this highly valuable support for companies has been sorely lacking and we’re looking forward to working with NAMTEC and a range of companies from across the region to help bring innovative products into the NHS for the benefit of the patient, the company and the regional economy.”
NAMTEC project manager, Helen Arthur, says: “Through access to specialist consultants, like Medipex, who have direct experience, we can work together to build and strengthen regional capability.”
Those interested in the services available through NAMTEC should contact Helen Arthur on helen.arthur@namtec.co.uk; and those interested in Medipex should contact Chris Herbert on chris.herbert@medipex.co.uk.
This was posted in Bdaily's Members' News section by Tom Keighley .
Enjoy the read? Get Bdaily delivered.
Sign up to receive our popular Yorkshire & The Humber morning email for free.
Celebrating Nissan's North East success story
Are you a meat proxy?
Engaging the five-generation workplace
Talent is an asset, not an operational resource
Taking advantage of the opportunities ahead
Accountability isn’t the enemy of empathy
Act now to avoid a last-minute tax scramble
How inner-city living can transform a city by the sea
Artificial intelligence's value is the time it gives back
Why we must break the magnetic pull of London
AI scepticism is healthy - inaction isn't
What does NPPF mean for planning gain and pricing?